Glucagon-like peptide-1 receptor agonists to treat chronic kidney disease associated with type 2 diabetes

被引：0
作者：
Khan, Irfan [1 ]
Lanktree, Matthew B. [2 ]
机构：
[1] Univ Coll Cork, Coll Med & Hlth, Cork, Ireland
[2] McMaster Univ, Dept Med Ainsi Que Methodes Donnees & Incidences R, Hamilton, ON, Canada
来源：
CANADIAN MEDICAL ASSOCIATION JOURNAL | 2025年 / 197卷 / 06期
关键词：
D O I：
10.1503/cmaj.240469-f
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E165 / E166
页数：2
相关论文
共 50 条
[31]   Treatment Strategy for Type 2 Diabetes with Obesity: Focus on Glucagon-like Peptide-1 Receptor Agonists [J].
Ji, Qiuhe .
CLINICAL THERAPEUTICS, 2017, 39 (06) :1244-1264
[32]   Glucagon-Like Peptide-1 Receptor Agonists and Liver Outcomes in Patients With MASLD and Type 2 Diabetes [J].
Kuo, Chia-Chih ;
Chuang, Min-Hsiang ;
Li, Chun-Hsien ;
Tsai, Ya-Wen ;
Huang, Po-Yu ;
Kuo, Hsing-Tao ;
Lai, Chih-Cheng .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2025, 61 (07) :1163-1174
[33]   Glucagon like peptide-1 receptor agonists in type 1 diabetes [J].
Deng, Chao ;
Fan, Wenqi ;
Li, Xia .
DIABETES & METABOLISM, 2023, 49 (06)
[34]   It Is Time to Consider Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Type 2 Diabetes in Youth [J].
Oberle, Megan M. ;
Kelly, Aaron S. .
FRONTIERS IN ENDOCRINOLOGY, 2019, 10
[35]   Glucagon-like peptide-1 receptor agonists and the cardiorenal axis in Type 2 diabetes: a focus on dulaglutide [J].
MacIsaac, Richard J. .
FUTURE CARDIOLOGY, 2021, 17 (03) :459-473
[36]   Long-term management of type 2 diabetes with glucagon-like peptide-1 receptor agonists [J].
Courtney, Hamish ;
Nayar, Rahul ;
Rajeswaran, Chinnadorai ;
Jandhyala, Ravi .
DIABETES METABOLIC SYNDROME AND OBESITY, 2017, 10 :79-87
[37]   Glucagon-Like Peptide-1 Receptor Agonists for Type 2 Diabetes: A Clinical Update of Safety and Efficacy [J].
Drab, Scott R. .
CURRENT DIABETES REVIEWS, 2016, 12 (04) :403-413
[38]   Glucagon-like peptide-1 receptor agonists and risk of acute pancreatitis in patients with type 2 diabetes [J].
Storgaard, Heidi ;
Cold, Frederik ;
Gluud, Lise L. ;
Vilsboll, Tina ;
Knop, Filip K. .
DIABETES OBESITY & METABOLISM, 2017, 19 (06) :906-908
[39]   Correction to: Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes: Their Use and Differential Features [J].
Katherine A. Lyseng-Williamson .
Clinical Drug Investigation, 2019, 39 :915-916
[40]   Glucagon-Like Peptide-1 Receptor Agonists and Osteoarthritis [J].
Felson, David T. .
NEW ENGLAND JOURNAL OF MEDICINE, 2024, 391 (17) :1643-1644
12345